Evertis selects Honeywell Aclar technology to enhance pharmaceutical packaging
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Globally, BRUKINSA is approved in more than 70 countries
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
BioNTech and Bristol Myers Squibb will jointly execute a broad clinical development program to evaluate and advance BNT327 across numerous solid tumor types
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
Operating income on consolidated basis increased by 38.10% at Rs 44.58 crore in Q4 FY25
Subscribe To Our Newsletter & Stay Updated